Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Multi-component crystals of an orally available HIF prolyl hydroxylase inhibitor

Multi-component crystals of an orally available HIF prolyl hydroxylase inhibitor

US Patent 11970450 · Granted Apr 30, 2024

Estimated economic value: $58,103,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Process for the preparation of crystalline ridinilazole using acid addition salt2022
Crystalline forms of cabotegravir sodium2021
Crystalline forms of cabotegravir sodium2021
Crystalline forms of valbenazine salts2021
Form C of avibactam sodium2019
Solid dispersion comprising an orexin receptor antagonist2019
Cabozantinib salts and their use as anti-cancer agents2019
Hydrates of dolutegravir sodium2019
Crystalline forms of cabozantinib phosphate and cabozantinib hydrochloride2018
1-[2-(2,4-dimethylphenylsulfanyl) phenyl]piperazine acetate in crystalline form2017
Process for the preparation of 3-aroyl-5-aminobenzofuran derivatives2016
Cyclic depsipeptides2015